Caboxamycin, a new antibiotic of the benzoxazole family produced by the deep-sea strain Streptomyces sp. NTK 937

Claudia Hohmann, Kathrin Schneider, Christina Bruntner, Elisabeth Irran, Graeme Nicholson, Alan Bull, Amanda Jones, Roselyn Brown, James Stach, Michael Goodfellow, Winfried Beil, Marco Krämer, Johannes Imhoff, Roderich Süssmuth, Hans-Peter Fiedler

    Research output: Contribution to journalArticlepeer-review

    176 Citations (Scopus)

    Abstract

    Caboxamycin, a new benzoxazole antibiotic, was detected by HPLC-diode array screening in extracts of the marine strain Streptomyces sp. NTK 937, which was isolated from deep-sea sediment collected in the Canary Basin. The structure of caboxamycin was determined by mass spectrometry, NMR experiments and X-ray analysis. It showed inhibitory activity against Gram-positive bacteria, selected human tumor cell lines and the enzyme phosphodiesterase
    Original languageEnglish
    Pages (from-to)99-104
    JournalJournal of Antibiotics
    Volume62
    DOIs
    Publication statusPublished - Feb 2009

    Fingerprint

    Dive into the research topics of 'Caboxamycin, a new antibiotic of the benzoxazole family produced by the deep-sea strain Streptomyces sp. NTK 937'. Together they form a unique fingerprint.

    Cite this